Library / regulatory-reference
Belgium: Federal Agency for Medicines and Health Products (FAMHP)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Federal Agency for Medicines and Health Products, known by its French and Dutch initials FAMHP and FAGG, is Belgium's national regulatory authority for medicines and health products.
Belgium is a major pharmaceutical production and export hub, hosting large manufacturing and distribution operations, so the agency's inspection and licensing work carries weight well beyond its domestic market.
How products enter the market
Medicines require marketing authorization through national or European procedures after evaluation of quality, safety and efficacy, and establishments are licensed and inspected by the agency.
Post-market work includes safety monitoring within the European alert network, inspections of manufacturers and distributors, and management of medicine-shortage reporting, a growing focus.
Regional and international role
The agency is a senior member of the European regulatory network, contributing assessments, inspections and expertise to shared European work.
Its oversight of one of Europe's densest pharmaceutical logistics corridors gives its distribution and anti-falsification work continental significance.
Using this profile
The agency publishes regulations, guidance and alerts in French, Dutch, German and English through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Belgium illustrates the hub regulator: a national authority whose inspection reach follows products across Europe.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.